S|P|O
RUNX2|subClassOf|protein_coding_gene
COL10A1|subClassOf|protein_coding_gene
RUNX2|subClassOf|gene
VEGFA|subClassOf|gene
MMP13|subClassOf|protein_coding_gene
valproic acid|interacts with|RUNX2
valproic acid|interacts with|CEBPB
COL10A1|subClassOf|gene
DDR2 (human)|subClassOf|gene
COL10A1|participates_in|Collagen chain trimerization
COL3A1|participates_in|Collagen chain trimerization
COL1A1|participates_in|Collagen chain trimerization
COL2A1|participates_in|Collagen chain trimerization
VEGFA|subClassOf|protein_coding_gene
COL10A1|participates_in|Collagen formation
MMP13|participates_in|Collagen formation
CEBPB|subClassOf|protein_coding_gene
MMP13|subClassOf|gene
MMP13|participates_in|Extracellular matrix organization
COL10A1|participates_in|Extracellular matrix organization
DIO2|has gene product|type II iodothyronine deiodinase (human)
Triiodothyronine|interacts with|type II iodothyronine deiodinase (human)
EPAS1|participates_in|Developmental Biology
CEBPB|participates_in|Developmental Biology
ARNT|subClassOf|protein_coding_gene
GANC|subClassOf|protein_coding_gene
ARNT|causes or contributes to condition|Melanoma
COL2A1|causes or contributes to condition|Melanoma
ARNT|participates_in|Metabolism
ACAN|participates_in|Metabolism
ARNT|participates_in|Cellular responses to stress
VEGFA|participates_in|Cellular responses to stress
ARNT|participates_in|Cellular response to hypoxia
HIF1A|participates_in|Cellular response to hypoxia
COL2A1|subClassOf|protein_coding_gene
ACAN|subClassOf|protein_coding_gene
DDR2 (human)|subClassOf|protein_coding_gene
SOX9|subClassOf|protein_coding_gene
COL2A1|participates_in|Extracellular matrix organization
aggrecan core protein (human)|participates_in|Extracellular matrix organization
aggrecan core protein (human)|subClassOf|AGC
COL2A1|participates_in|Collagen biosynthesis and modifying enzymes
COL10A1|participates_in|Collagen biosynthesis and modifying enzymes
COL2A1|participates_in|Assembly of collagen fibrils and other multimeric structures
COL1A1|participates_in|Assembly of collagen fibrils and other multimeric structures
COL2A1|causes or contributes to condition|Spondyloepiphyseal dysplasia
VEGFA|causes or contributes to condition|Spondyloepiphyseal dysplasia
ACAN|subClassOf|gene
COL2A1|subClassOf|gene
VEGFA|causes or contributes to condition|Schwartz-Jampel syndrome
KDR|causes or contributes to condition|Schwartz-Jampel syndrome
VEGFA|causes or contributes to condition|Osteosarcoma
RUNX2|causes or contributes to condition|Osteosarcoma
VEGFA|causes or contributes to condition|Prostate neoplasm
MMP13|causes or contributes to condition|Prostate neoplasm
VEGFA|causes or contributes to condition|Melnick-Needles syndrome
COL2A1|causes or contributes to condition|Melnick-Needles syndrome
HIF1A|subClassOf|protein_coding_gene
HIF1A|causes or contributes to condition|Abnormal lung morphology
VEGFA|causes or contributes to condition|Abnormal lung morphology
VHL|participates_in|Cellular response to hypoxia
Triiodothyronine|molecularly interacts with|regulation of signaling
aflatoxin B1|molecularly interacts with|regulation of signaling
aflatoxin B1|interacts with|EPAS1
valproic acid|interacts with|P4HTM (human)
valproic acid|interacts with|HIF1A
CNMD|subClassOf|protein_coding_gene
EPAS1|subClassOf|protein_coding_gene
KDR|participates_in|VEGFA-VEGFR2 Pathway
PIK3CA|participates_in|VEGFA-VEGFR2 Pathway
KDR|participates_in|Axon guidance
MAPK3|participates_in|Axon guidance
MAPK1|participates_in|VEGFA-VEGFR2 Pathway
KDR|causes or contributes to condition|myocardial ischemia
JAK2|causes or contributes to condition|myocardial ischemia
KDR|participates_in|VEGFR2 mediated cell proliferation
PRKCA (human)|participates_in|VEGFR2 mediated cell proliferation
KDR|participates_in|Developmental Biology
RELA|participates_in|Developmental Biology
KDR|causes or contributes to condition|tubular adenocarcinoma
NFKB1|causes or contributes to condition|tubular adenocarcinoma
KDR|subClassOf|protein_coding_gene
RELB|subClassOf|protein_coding_gene
JUND|subClassOf|protein_coding_gene
JUNB|causes or contributes to condition|myocardial ischemia
FOS|subClassOf|protein_coding_gene
KDR|causes or contributes to condition|Schizophrenia
JUN|causes or contributes to condition|Schizophrenia
FOSL2|subClassOf|protein_coding_gene
FOSL1|subClassOf|protein_coding_gene
FOSB|subClassOf|protein_coding_gene
KDR|participates_in|Signal Transduction
HIF1A|participates_in|Signal Transduction
PIK3CA|participates_in|Signaling by Insulin receptor
AKT1|participates_in|Signaling by Insulin receptor
PIK3CA|participates_in|Adaptive Immune System
AKT2|participates_in|Adaptive Immune System
PIK3CA|participates_in|Signaling by ERBB2
AKT3|participates_in|Signaling by ERBB2
NGF|causes or contributes to condition|hereditary sensory and autonomic neuropathy
NTRK1|causes or contributes to condition|hereditary sensory and autonomic neuropathy
NGF|causes or contributes to condition|Depression
trans-resveratrol|is substance that treats|Depression
trans-resveratrol|molecularly interacts with|Endothelial cell proliferation
NGF|causes or contributes to condition|Tubulointerstitial nephritis
steroid|is substance that treats|Tubulointerstitial nephritis
steroid|molecularly interacts with|Tube formation
NTRK1|causes or contributes to condition|Lewy bodies
autosomal dominant Parkinson disease 4|has phenotype|Lewy bodies
RAS|is substance that treats|autosomal dominant Parkinson disease 4
oxygen atom|is substance that treats|Hypoxemia
oxygen atom|interacts with|HIF1A
desiccated thyroid extract|has part|L-thyroxine
desiccated thyroid extract|has part|Triiodothyronine
hydrocarbon|molecularly interacts with|Endothelial cell proliferation
hydrocarbon|molecularly interacts with|Tube formation
amide|molecularly interacts with|Tube formation
amide|molecularly interacts with|Endothelial cell proliferation
valproic acid|interacts with|JUND
valproic acid|interacts with|CCN2
JUND|causes or contributes to condition|Status epilepticus
NGF|causes or contributes to condition|Status epilepticus
diazinon|interacts with|JUND
diazinon|interacts with|JUNB
valproic acid|interacts with|FOS
JUN|causes or contributes to condition|Status epilepticus
valproic acid|interacts with|FOSL2
JUND|causes or contributes to condition|Neoplasm of the lung
FOSB|causes or contributes to condition|Neoplasm of the lung
CCN2|causes or contributes to condition|tubular adenocarcinoma
sodium arsenite|is substance that treats|tubular adenocarcinoma
sodium arsenite|molecularly interacts with|Endothelial cell proliferation
valproic acid|molecularly interacts with|Tube formation
JUNB|participates_in|Generic Transcription Pathway
CCN2|participates_in|Generic Transcription Pathway
JUNB|causes or contributes to condition|Status epilepticus
JUNB|participates_in|Gene expression (Transcription)
FOS|participates_in|Gene expression (Transcription)
JUN|participates_in|Gene expression (Transcription)
aflatoxin B1|interacts with|JUNB
aflatoxin B1|interacts with|FOSL2
JUNB|subClassOf|protein_coding_gene
CCN2|participates_in|Gene expression (Transcription)
FOS|causes or contributes to condition|Status epilepticus
FOS|causes or contributes to condition|Status epilepticus without prominent motor symptoms
JUNB|causes or contributes to condition|Status epilepticus without prominent motor symptoms
FOS|participates_in|Toll Like Receptor 3 (TLR3) Cascade
JUN|participates_in|Toll Like Receptor 3 (TLR3) Cascade
JUN|causes or contributes to condition|Status epilepticus without prominent motor symptoms
NGF|causes or contributes to condition|Status epilepticus without prominent motor symptoms
JUN|subClassOf|protein_coding_gene
JUN|participates_in|Immune System
FOS|participates_in|Immune System
JUN|causes or contributes to condition|Neoplasm of the lung
aflatoxin B1|interacts with|NGF
FOSL2|causes or contributes to condition|Neoplasm of the lung
CCN2|subClassOf|protein_coding_gene
NGF|subClassOf|protein_coding_gene
FOSB|causes or contributes to condition|Seizure
NGF|causes or contributes to condition|Seizure
JUNB|causes or contributes to condition|Neoplasm of the lung
FOSB|causes or contributes to condition|Focal sensory seizure
FOS|causes or contributes to condition|Focal sensory seizure
FOSB|causes or contributes to condition|Neoplasm of the liver
JUN|causes or contributes to condition|Neoplasm of the liver
RELA|causes or contributes to condition|Neoplasm of the breast
IBSP|causes or contributes to condition|Neoplasm of the breast
RELA|participates_in|Signal Transduction
SPP1|participates_in|Signal Transduction
RELA|participates_in|Cytokine Signaling in Immune system
VEGFA|participates_in|Cytokine Signaling in Immune system
RELA|causes or contributes to condition|Extrahepatic cholestasis
CCN2|causes or contributes to condition|Extrahepatic cholestasis
RELA|participates_in|NF-kB is activated and signals survival
NGF|participates_in|NF-kB is activated and signals survival
RELA|participates_in|Toll Like Receptor 2 (TLR2) Cascade
NFKB1|participates_in|Toll Like Receptor 2 (TLR2) Cascade
RELA|participates_in|Innate Immune System
RELB|participates_in|Innate Immune System
IBSP|participates_in|Extracellular matrix organization
matrix metalloproteinase-14 (human)|participates_in|Extracellular matrix organization
matrix metalloproteinase-14 (human)|participates_in|Endothelial cell proliferation
polycyclic arene|is substance that treats|Neoplasm of the breast
polycyclic arene|molecularly interacts with|Tube formation
IBSP|causes or contributes to condition|Osteolysis
SPP1|causes or contributes to condition|Osteolysis
SPP1|causes or contributes to condition|adenocarcinoma
sodium arsenite|is substance that treats|adenocarcinoma
SPP1|causes or contributes to condition|Cerebral hemorrhage
valproic acid|is substance that treats|Cerebral hemorrhage
SPP1|participates_in|Extracellular matrix organization
NFKB1|subClassOf|protein_coding_gene
IBSP|subClassOf|protein_coding_gene
SPP1|causes or contributes to condition|tubular adenocarcinoma
NFKB1|participates_in|Developmental Biology
VEGFA|participates_in|Developmental Biology
NFKB1|causes or contributes to condition|adenocarcinoma
CCN2|causes or contributes to condition|adenocarcinoma
NFKB1|participates_in|p75NTR signals via NF-kB
NGF|participates_in|p75NTR signals via NF-kB
valproic acid|interacts with|NFKB1
valproic acid|interacts with|RELA
NFKB1|participates_in|CLEC7A (Dectin-1) signaling
RELB|participates_in|CLEC7A (Dectin-1) signaling
SPP1|subClassOf|protein_coding_gene
RELB|participates_in|Cytokine Signaling in Immune system
RELB|participates_in|CD209 (DC-SIGN) signaling
NFKB1|participates_in|CD209 (DC-SIGN) signaling
MAPK3|subClassOf|protein_coding_gene
MAPK3|participates_in|Disease
aggrecan core protein (human)|participates_in|Disease
valproic acid|interacts with|MAPK3
valproic acid|interacts with|COL2A1
MAPK3|participates_in|Gene expression (Transcription)
RUNX2|participates_in|Gene expression (Transcription)
MAPK3|participates_in|VEGFR2 mediated cell proliferation
VEGFA|participates_in|VEGFR2 mediated cell proliferation
MAPK3|causes or contributes to condition|Prostate cancer
MMP13|causes or contributes to condition|Prostate cancer
MAPK3|participates_in|Interleukin receptor SHC signaling
MAPK1|participates_in|Interleukin receptor SHC signaling
valproic acid|interacts with|MAPK1
valproic acid|interacts with|SOX9
MAPK1|participates_in|Disease
MAPK1|subClassOf|protein_coding_gene
VEGFA|participates_in|VEGFA-VEGFR2 Pathway
MAPK1|participates_in|MAP2K and MAPK activation
MAPK3|participates_in|MAP2K and MAPK activation
JAK2|participates_in|Interleukin-6 signaling
STAT3|participates_in|Interleukin-6 signaling
FGFR1|participates_in|Role of LAT2/NTAL/LAB on calcium mobilization
PIK3CA|participates_in|Role of LAT2/NTAL/LAB on calcium mobilization
FGFR1|participates_in|Signal Transduction
glial cell line-derived neurotrophic factor (human)|participates_in|Signal Transduction
RAS|interacts with|glial cell line-derived neurotrophic factor (human)
FGFR1|causes or contributes to condition|Beare-Stevenson cutis gyrata syndrome
Beare-Stevenson cutis gyrata syndrome|disease has basis in dysfunction of|FGFR2
FGFR1|participates_in|VEGFA-VEGFR2 Pathway
FGFR3|participates_in|VEGFA-VEGFR2 Pathway
FGFR1|participates_in|Interleukin-3, Interleukin-5 and GM-CSF signaling
FGFR4|participates_in|Interleukin-3, Interleukin-5 and GM-CSF signaling
FGFR1|participates_in|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
LAMTOR1|participates_in|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGFR2|participates_in|Interleukin-2 family signaling
PIK3CA|participates_in|Interleukin-2 family signaling
FGFR2|participates_in|NCAM signaling for neurite out-growth
glial cell line-derived neurotrophic factor (human)|participates_in|NCAM signaling for neurite out-growth
FGFR2|participates_in|Fc epsilon receptor (FCERI) signaling
FGFR1|participates_in|Fc epsilon receptor (FCERI) signaling
FGFR2|participates_in|Signaling by GPCR
FGFR3|participates_in|Signaling by GPCR
FGFR4|participates_in|Interleukin-2 family signaling
FGFR2|participates_in|Signaling by Insulin receptor
LAMTOR1|participates_in|Signaling by Insulin receptor
FGFR3|participates_in|Signaling by FGFR3 in disease
PIK3CA|participates_in|Signaling by FGFR3 in disease
valproic acid|interacts with|FGFR3
valproic acid|is substance that treats|Memory impairment
RAS|is substance that treats|Memory impairment
FGFR3|participates_in|Prolonged ERK activation events
FGFR1|participates_in|Prolonged ERK activation events
FGFR3|causes or contributes to condition|Saethre-Chotzen syndrome
FGFR2|causes or contributes to condition|Saethre-Chotzen syndrome
FGFR3|participates_in|Interleukin receptor SHC signaling
FGFR4|participates_in|Interleukin receptor SHC signaling
FGFR3|participates_in|IRS-related events triggered by IGF1R
LAMTOR1|participates_in|IRS-related events triggered by IGF1R
FGFR4|participates_in|RET signaling
glial cell line-derived neurotrophic factor (human)|participates_in|RET signaling
FGFR4|participates_in|Signalling to p38 via RIT and RIN
FGFR1|participates_in|Signalling to p38 via RIT and RIN
FGFR4|participates_in|Prolonged ERK activation events
FGFR2|participates_in|Prolonged ERK activation events
FGFR3|participates_in|Interleukin-2 family signaling
FGFR4|participates_in|Insulin receptor signalling cascade
LAMTOR1|participates_in|Insulin receptor signalling cascade
PIK3CA|participates_in|Insulin receptor signalling cascade
LAMTOR1|participates_in|Innate Immune System
transcription factor p65 (human)|participates_in|Innate Immune System
RAS|interacts with|transcription factor p65 (human)
FGFR1|participates_in|Signaling by Insulin receptor
FGFR2|participates_in|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
FGFR3|participates_in|Signaling by Insulin receptor
FGFR4|participates_in|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
transcription factor p65 (human)|participates_in|Toll Like Receptor 9 (TLR9) Cascade
MAPK1|participates_in|Toll Like Receptor 9 (TLR9) Cascade
RAS|is substance that treats|amnestic disorder
genistein(1-)|is substance that treats|amnestic disorder
genistein(1-)|interacts with|MAPK3
AKT1|subClassOf|gene
AKT1|subClassOf|protein_coding_gene
AKT1|participates_in|Cytokine Signaling in Immune system
AKT1|participates_in|Signal Transduction
SOX9|participates_in|Signal Transduction
AKT1|participates_in|Metabolism
aggrecan core protein (human)|participates_in|Metabolism
AKT1|participates_in|IRS-related events triggered by IGF1R
AKT2|participates_in|IRS-related events triggered by IGF1R
AKT1|participates_in|CD28 co-stimulation
AKT3|participates_in|CD28 co-stimulation
AKT2|participates_in|Gene expression (Transcription)
AKT2|subClassOf|protein_coding_gene
AKT2|participates_in|Signal Transduction
VEGFA|participates_in|Signal Transduction
AKT2|subClassOf|gene
AKT2|participates_in|Disease
AKT2|participates_in|Costimulation by the CD28 family
AKT1|participates_in|Costimulation by the CD28 family
AKT2|participates_in|Intrinsic Pathway for Apoptosis
AKT3|participates_in|Intrinsic Pathway for Apoptosis
AKT3|participates_in|Gene expression (Transcription)
AKT3|subClassOf|protein_coding_gene
AKT3|participates_in|Generic Transcription Pathway
VEGFA|participates_in|Generic Transcription Pathway
AKT3|subClassOf|gene
AKT3|participates_in|Signal Transduction
AKT3|participates_in|Disease
AKT3|participates_in|VEGFR2 mediated vascular permeability
AKT1|participates_in|VEGFR2 mediated vascular permeability
AKT3|participates_in|Transcriptional Regulation by TP53
AKT2|participates_in|Transcriptional Regulation by TP53
SOX9|has gene product|transcription factor SOX-9 (human)
transcription factor SOX-9 (human)|molecularly interacts with|aggrecan core protein (human)
aggrecan core protein (human)|molecularly interacts with|transcription factor SOX-9 (human)
transcription factor SOX-9 (human)|has_gene_template|SOX9
FGF23|participates_in|VEGFA-VEGFR2 Pathway
FGF23|participates_in|Negative regulation of the PI3K/AKT network
FGFR2|participates_in|Negative regulation of the PI3K/AKT network
FGF23|participates_in|Signalling to p38 via RIT and RIN
FGFR3|participates_in|Signalling to p38 via RIT and RIN
FGF23|participates_in|IRS-related events triggered by IGF1R
FGFR4|participates_in|IRS-related events triggered by IGF1R
FGF23|participates_in|Insulin receptor signalling cascade
COL3A1|subClassOf|gene
COL3A1|participates_in|Collagen biosynthesis and modifying enzymes
COL3A1|participates_in|Extracellular matrix organization
COL1A1|participates_in|Extracellular matrix organization
COL3A1|participates_in|Collagen formation
COL2A1|participates_in|Collagen formation
COL1A1|subClassOf|protein_coding_gene
COL1A1|causes or contributes to condition|Extrahepatic cholestasis
COL3A1|causes or contributes to condition|Extrahepatic cholestasis
COL1A1|participates_in|Collagen biosynthesis and modifying enzymes
